| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Bormann-Kennedy Barbara-Jean Anne is a Director at Xeris Biopharma Holdings, Inc.. Recent SEC Form 4 filings include 0 buys and 1 sell.
Estimated insider holdings value: $931K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | XERS Xeris Biopharma Holdings, Inc. | Director | Sell | 15,000 | $7.09 | $106,414.50 | -9.5% | -23.6% | - |